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III. Abstract

Fetal alcohol syndrome (FAS) occurs in 0.2 to 1.5 per 1,000 infants born. FAS results in
symptoms such as abnormal craniofacial features, impaired cognitive abilities and cardiovascular
defects. However, the impact of prenatal ethanol exposure on the neural crest cells responsible
for cardiac innervation remains understudied. This study investigates the effect of variable
timing of ethanol treatment on cardiac and trunk neural crest cells and the subsequent impact on
cardiac innervation. Early ethanol treatment led to decreased apoptosis in the neural tube and
increased apoptosis in the migratory pathway towards the outflow tract in the cardiac neural
crest. Early ethanol exposure also decreased cardiac neural crest cell migration in the cardiac
circumpharyngeal ridge and increased neural crest cell migration in the pharyngeal arches. Later
ethanol exposure resulted in increased apoptosis in the trunk neural crest region of the neural
tube and decreased neuronal branching on the anterior base of the outflow tract. Later ethanol
exposure also substantially increased migration in the circumpharyngeal ridge in the trunk neural
crest and slightly increased migration in the cardiac neural crest region of the circumpharyngeal
ridge. These findings suggest that early ethanol exposure may lead to a lack of selection for the
proper neural crest cells reaching the heart necessary for survival, and that later alcohol treatment
shows a similar impairment in the selection process for neural crest arriving to the heart,
resulting in reduced cardiac neuron branching. Further studies can determine how cardiac
innervation is influenced by varying concentrations of neural crest arriving to the heart and how
apoptosis shapes the directionality and specification of the migratory pathway.
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IV. Introduction
A. Fetal Alcohol Syndrome

Fetal Alcohol Syndrome (FAS) is a term used to correlate maternal drinking with abnormal
facial features, growth problems, cognitive disabilities, and even death in fetuses. The CDC
estimates that 0.2 to 1.5 per 1,000 infants born show FAS (Streissguth et al., 1996). FAS
describes the more critical cases of Fetal Alcohol Spectrum Disorders (FASD), which occur due
to pre-natal alcohol exposure (PAE). Although the effects of PAE on fetuses are widely known,
infants continue to be born with birth defects attributed to alcohol (ethanol) exposure. This
finding could be due to the large number of unintended pregnancies, and gestating individuals
who are unaware that they are pregnant. Embryos are particularly vulnerable to ethanol-related
defects during the first six weeks of human development, as the development of vital organs
occur during this time. Critical developmental events such as heart development occurs within
the first 10 weeks of gestation, so if individuals are not aware of the pregnancy during this time,
they may accidentally expose the fetus to ethanol or other teratogens. Cardiac defects are
especially problematic and call for further research because nutrition, oxygenation, and removal
of waste, all functions of the heart, are vital to survival and development (Karunamuni et al.,
2014).
It is important to understand the molecular basis of these pathologies in order to treat or prevent
conditions associated with FAS. induces oxidative stress by suppressing the synthesis of
antioxidants and increasing the synthesis of free radicals, which enhances apoptosis, and reduces
neuron development (Guerri 1998).
FAS has also been associated with alcohol-induced DNA and histone methylation. Methylation
then leads to variable gene expression, resulting in changes in cell proliferation, differentiation,
apoptosis, as well as intracellular signaling pathways (Goodlett 2001). This study aims to focus
on how these cellular and molecular changes affect the developing heart.
B. Cardiac development

The cardiovascular system is essential in early development since it transports oxygen and
nutrients to all tissues for metabolism. Within the first three weeks of human gestation, the
8

embryonic heart tube begins to form, the heart is innervated at weeks 5-6, and the heart is
considered fully functional by week 7 (de Bour et al., 2012).
Onset of neural control in the developing heart requires the presence of muscarinic-cholinergic
receptors which bind the neurotransmitter acetylcholine, promote parasympathetic activity and
initiate the first heart beats. Next, the B-adrenergic receptors allow for binding of norepinephrine
and epinephrine which stimulate sympathetic activity in the heart (Papp, 1998).
Autonomic cardiac innervation are also vital to cardiomyocyte development and contraction, and
if neuronal development is impaired, this impairment may result in some of the abnormal heart
function often seen in FAS patients.
Cardiomyocyte size in the epicardium is correlated with the amount of sympathetic neurocardiac cell junctions in mammals, including humans (Pianca et al., 2019). Simultaneous
activation of the many β-adrenergic receptors upon neuronal norepinephrine discharge in the
epicardium inhibits atrophy and promotes cardiomyocyte growth in the developing heart (Pianca
et al., 2019)
Because we cannot ethically induce FAS in human embryos, this study will use the avian (Gallus
gallus) model to study cardiac innervation development. Thus, a brief description of general
avian development and chick heart development is warranted.
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The shelled avian embryo (left) develops in amniotic cavity which provides an aqueous
environment for development. The allantois in both the avian and mammalian embryo carries
waste away from the embryo. In the avian embryo, the yolk sac allows for gas exchange. In both
embryos, the blood vessels of the chorion exchange nutrients. The avian embryo exchanges
nutrients with the yolk sac while the mammalian embryo exchanges nutrients and gas with the
placenta joined to the mother’s uterus (Figure 12.1 Developmental Biology, 2016)
Within the first three days of development, the chick heart develops from heart fields (termed
FHF and SHF depending on whether they form the initial heart tube or contribute later during
development, respectively), to a heart tube (HT), to a two-chambered tube (HH 18). In the avian
model, the heart tube is functional by HH 10-11. In humans this occurs by the third week of
gestation. The atrium receives blood through the vitelline veins and the ventricles pump blood
out of the aortic sac. The heart loops, the forming atria converge with the outflow tract, and
septation occurs to form a four-chambered heart (Manner, 2000).

Figure 1. Cardiac morphogenesis in chick.
A, atrium; C, conus, CNC, cardiac neural crest; HT heart tube; LA/RA, left/right atrium; LV/RV, left/right ventricle (Wittig
2016).

This figure depicts the cardiac neural crest cells migrating to the developing heart to aid in
morphogenesis. Cardiac morphogenesis is just one of the many processes in which neural crest
cells play a role.
C. Neural crest cells

Neural crest cells are multipotent and migratory cells that determine the fate of many embryonic
structures, including those in the nervous, cardiovascular, and gastrointestinal systems. NCC
10

migrate from the neural crest during neurulation (HH 8–9 in chicken embryos) (Karunamuni et
al. 2014).

Figure 2. The formation of the neural tube and the subsequent migration of neural crest cells.
The ectoderm begins folding, creating a ventral neural tube (blue) that separates from the dorsal epidermal ectoderm (gray). The
lumen of the neural tube is the future ventricle of the brain. The cells at the junction of the neural and non-neural ectoderm
(green) will give rise to the neural crest (Tyler, M. S., 1994).

The dorsal side of the neural tube forms as a result of BMP and noggin signaling while
the notochord releases Sonic Hedgehog signals that induce ventral fate of the neural tube.
Although the neural tube forms on the dorsal side of the embryo, promoted by the epiblast and
retinoic acid, the ventral side also releases signaling molecules which determine neural crest cell
(NCC ) fate. Motor neurons and sensory neurons also come from the neural tube.
NCC are subdivided into four overlapping populations, including the cranial neural crest cells;
cardiac neural crest cells, which are within the cranial neural crest cell region; trunk neural crest
cells; and sacral neural crest cells. These cells migrate from the junction of the neural tube and
the ectoderm to give rise to various cell and tissue types.
11

Figure 3. Cardiac and trunk NCC contribute to cardiac innervation.
The cardiac NCC give rise to the parasympathetic innervation of the heart, while the trunk NCC contribute to the sympathetic
innervation of the heart (Kirby and Waldo, 2007).

Cardiac neural crest cells, which migrate from the neural tube at the level of somites (i.e.,
mesenchymal building blocks) 1-3, give rise to parasympathetic cardiac innervation and
contribute to cardiac morphology. This morphology includes septation of the aorta and
pulmonary artery, as well as producing the endothelium of thee aortic arch arteries (Kirby and
Waldo, 2007). At HH 4-5, cardiac neural crest cells are undergoing the initial specification to
become potential NC, and begin migrating toward the developing heart at HH 10.
Trunk NCC control the fate of the sympathetic nervous system by the SHP-2 protein (Src
homology protein-tyrosine phosphatase 2) and regulates late-stage cardiac function(Lajiness et
al., 2014). The trunk neural crest cells begin migrating to the developing heart at HH 11-15
(Hamburger and Hamilton, 1951; Schultheiss and Lassar, 1999). Trunk NCC migrate towards
the ventral side of the body, passing through somites 10-20 “to establish the sympathetic trunk
ganglia near the dorsal aorta” Trunk NCC continue to differentiate via BMP signaling (Lajiness
et al., 2014). Further differentiation into the cardiac plexus is induced by migration to the
cervicothoracic and intrinsic cardiac ganglia (Lajiness et al., 2014). Nerve growth factor (NGF)
then further differentiates the sympathetic neurons through the “SHP-2 (Src homology proteintyrosine phosphatase 2)/ERK pathway” during postnatal development, which is initiated by
postmigratory NCC lineages (Lajiness et al., 2014). Although the sympathetic innervation is
12

initiated early development, it does not show its vital importance in the maintenance of basal
heart rate until postnatal development.
D. Ethanol exposure targets neural crest cells

Fetal alcohol syndrome is increasingly being researched at the molecular level through
epigenetics as well as developmental biology studies. One such research topic is the effect of
high maternal ethanol consumption on embryonic cardiac neural crest cell function and
formation, and the subsequent cardiac abnormalities that result from this exposure. Neural crest
cells, in particular, are vulnerable to teratogens such as ethanol because they are highly
proliferative, multipotent, and migrate extensively throughout the developing embryo to
contribute to vital anatomical structures and physiological processes (Karunamuni et al., 2014).
Certain assumptions have been established in progressing towards understanding this
vulnerability:
(1) Impairing NCC function leads to congenital heart disorders (CHDs)
(2) FAS leads to CHDs
(3) FAS impairs NCC
(4) both FAS and NCC impairments affect cardiac function
and (5) abnormal cardiac function can lead to CHDs (Karunamuni et al., 2014).
This thesis will use these assumptions to examine how ethanol impairs neural crest cells and the
autonomic nervous system development and how these defects then lead to congenital heart
defects.
E. Early ethanol exposure targets cardiac neural crest cells

Ethanol exposure, which simulates binge-drinking conditions in early development, has been
shown to lead to congenital defects produced by impairment in neural crest cell populations. The
cranial defects in relation to the affected cranial neural crest cells have been extensively
researched to explain FASD related anomalies such as short palpebral fissures, short nose, flat
midface, thin upper lip, and indistinct philtrum (Streissguth 1996). However, the FASD related
cardiovascular defects in relation to the cardiac neural crest subset of the cranial neural crest cell
population remain insufficiently examined.
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Figure 4. Ethanol exposure at gastrulation/neurulation stages causes cardiac NCC abnormalities that lead to poor heart
function. Ethanol directly affects neural crest cell survival and may indirectly affect overall heart function and endocardial
cushion formation (Karunamuni et al., 2014).

Clinical studies have shown that infants with FAS have reduced parasympathetic activity in the
heart and reduced heart rate variability, without accompanying increased sympathetic activity
(Oberlander et al., 2010). To determine the cause of these defects, animal models have been
generated to mimic the human phenotype. Exposing mice and chick models to low levels of
ethanol (i.e., the equivalent of one drink) can simulate the maternal alcohol consumption that
leads to Fetal Alcohol Disorders. Ethanol inhibits the function of cell adhesion protein L1, which
then impedes the differentiation and migration of NCC derivatives (Karunamuni et al., 2014).
For the cardiac NCC in particular, migration towards the circumpharyngeal ridge, the
pharyngeal arches, and the aortic arch arteries is reduced, resulting in abnormal valve leaflets,
abnormal conduction, reduced shear forces and, consequently, abnormal endocardial cushions
(Karunamuni et al., 2014). Thus, the aorta and pulmonary trunk do not separate efficiently,
leading to PTA (Karunamuni et al., 2014).
Intriguingly, the defects observed in response to alcohol exposure look similar to what happens
when the cardiac NCC is ablated in chicken and mouse embryos. After cardiac NCC ablation,
the embryonic outflow tract remains unseptated, also known as persistent truncus arteriosus
(PTA) (Karunamuni et al., 2014). Cardiac NCC apoptosis can also lead to small pharyngeal
arches, ventricular septal defects, atrial septal defects, and low calcium transients in the
14

developing heart (Karunamuni et al., 2014). These results are comparable to the Fetal Alcohol
Syndrome-correlated atrial and ventricular septal defects (Popova et al., 2019).

Figure 5. Potential consequences of NCC depletion.
During normal development (left side) cardiac neural crest (CNC) cells from otic placode (Oto) to somite 3 (S3) travel from the
cardiac NCC through the circumpharyngeal ridge to enter the pharyngeal arches, aorttic arch, and outflow tract (OFT). FAS
induces cell death, causing fewer NCC arriving at the heart. The neural tubes at the top depict the neural crest at HH 9–10, and
the hearts at the bottom show the heart at approximately HH 31 (Karunamuni et al., 2014).

Calcium increases within the cardiac NCC , leading to apoptosis and decreased calcium
transients in the heart (Karunamuni et al., 2014). This increase can then be rescued by inhibiting
CaMKII inhibitors (Karunamuni et al., 2014). The depressed calcium transients in the
developing heart previously exposed to ethanol, result in reduced cardiac contractility
(Karunamuni et al., 2014).
F. Later ethanol exposure targets trunk neural crest cells

Using the 5th assumption (Figure 5) regarding the connections among ethanol, NCC s, and
congenital heart defects, stunted cardiac conductance, which is an example of abnormal
cardiovascular function, can thus lead to a congenital heart disorder. Although normal
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conductance does not develop until after birth, it is shaped prior to birth via the trunk neural crest
cells.
In post-natal mammals that had been exposed to ethanol during embryogenesis, the adrenergic
receptors are overexpressed and prematurely develop, suggesting a compensation for delayed
onset of sympathetic innervation (Bond 1988, Zimmerberg et al., 1996). The impact of FAS on
sympathetic neuronal function is still unclear. This study will focus on observing possible effects
of FAS on the superficial cardiac plexus of the sympathetic branch.
G. The current study

Ethanol produces congenital heart defects by producing an unfavorable environment for neural
crest cells, leading to apoptosis, stunting migration and calcium regulation, and depressing the
dopamine levels that promote sympathetic innervation. Because both the cardiac and trunk
neural crest contribute neurons to the heart, the present study will address whether the
derivatives of neural crest are variably impacted by early ethanol exposure. The chick embryo
will be exposed to ethanol when cardiac (HH 4-5) or trunk (HH 11-12) neural crest delamination
begins. The variable treatment periods are to account for the variable migration timing of the
NCC subpopulations. Thus, ethanol will target either cardiac or trunk neural crest cells.
To assess whether the cardiac and trunk neural crest cells are similarly impacted by early ethanol
exposure, I will use immunohistochemistry to analyze neural crest cell migration and apoptosis
in HH 18 or HH 26 embryos as well as in cardiac innervation and apoptosis in the developing
heart of HH 31-36 embryos. Observations will focus on whether either neural crest cell
derivative correlates with changes in parasympathetic and sympathetic neuron branching
patterns. By exposing the embryo to ethanol at variable time points during development, NCC
derivative targeting is variable; thus, I expect variable effects on cardiac innervation.
V. Methods
A. In ovo treatment

Fertilized eggs from Meyer Hatchery (Polk, OH) were held in a 14 refrigerator until incubation
in a 37C humidified environment to begin development. The eggs were either incubated for 24
h (HH 4-HH 5) to target the cranial NCCs or 48 h (HH 10-HH 12) to target the trunk NCCs
before being windowed, and embryos were staged using neutral red dye (Tyler 1994). Embryos
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then received either a 10 L dose of 0.9% sterile saline (NS) or 100 mM ethanol (EtOH) (0.58%
EtOH in 0.9% NS), which is within the clinically relevant range for inducing fetal alcohol
syndrome in humans (Tyler 1994). Eggs were then sealed and returned to the incubator to
continue development.
Whole embryos were collected at day 3 (HH 20-21) or 5 (HH 25-27), and hearts were collected
at day 7 (HH 30-31), 8 (HH 33-34), or 10 (HH 36). Embryos and heart samples were incubated
at 37°C with 1/1000 LysoTracker Red DND-99 (ThermoFisher Scientific) in 1x phosphatebuffered saline (PBS, pH 7.4) for 10 minutes to track apoptotic cells. Samples were then washed
3x15 minutes in PBS and fixed overnight in 4% paraformaldehyde. All samples were protected
from light throughout the protocol to minimize photobleaching of light-sensitive probes such as
Lysotracker Red and the secondary antibodies.
B. Whole-mount Immunohistochemistry

After fixation, all samples were rinsed 3x15 minutes in PBS and dehydrated in 100% methanol
overnight at -20°C. Samples were then rehydrated using a methanol and PBS gradient.
i.

Tuj-1 labeling

Hearts from HH 33 embryos were then washed 2x1 hour in PBS + 2% powdered skim milk +
0.1% triton (PBSMT) and incubated with the anti-TUJ-1 antibody (Mouse IgG2a, Neuromics)
diluted 1:500 in PBSMT overnight at 4°C to identify neurons. The hearts were then washed 3x1
hour in PBSMT and incubated overnight in an AlexaFluor 488-conjugated goat anti-mouse
secondary antibody (ThermoFisher Scientific) diluted 1:200 in PBSMT.
ii.

Hnk-1 labeling

HH 20-26 embryos were pretreated with proteinase K (10 μg/ml) for 8-10 min, washed 2x1 hour
in Tris + 5% fetal bovine serum (FBS). The anti-HNK antibody (Mouse IgG1, Developmental
Studies Hybridoma Bank, University of Iowa) was diluted 1:10 in Tris + 5% FBS and applied to
the embryos to tag migrating NCC s. Then, the embryos were washed 3x1 hour in Tris + 5%
FBS and incubated in an AlexaFluor 488-conjugated goat anti-mouse secondary antibody
(ThermoFisher Scientific) diluted 1:200 in Tris + 5% FBS overnight. All samples were then
washed 3x1 hour in PBS.
C. Imaging
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Samples were photographed using fluorescent microscopy Olympus SZX16 and HCImageLive.
Low magnification was used to image whole hearts, higher magnification was used to analyze
the superficial cardiac plexus at the base of the great arteries. Embryos were imaged at two
positions: the anterior portion of the embryo capturing the cardiac NC, and the medial/posterior
portion of the embryo, capturing the trunk NCC .
Magnification

Pixels per 1 mm

1.60

240.000

2.00

306.015

2.25

357.113

3.20

510.141

3.50

513.008

4.50

690.059

5.50

876.128

6.00

912.065
Table 1. Image Magnification and pixels per 1 mm for analysis.

Images were then analyzed in Photoshop to increase contrast of HNK-1 and TUJ-1 against
Lysotracker red.
D. Data collection and imaging analysis
The survival rate for each treatment was determined at the day of harvest. Cardiac NC-targeted
embryos were harvested at incubation day 3, 5, or 8, and trunk NC-targeted embryos were
harvested at incubation day 3, 5, 7, 8, 9, and 10.
ImageJ and Fiji software were used to collect neuron data. ImageJ was also used to count
apoptotic cells and measure the area and fluorescent intensity of migrating NCC s.
The number of apoptotic cells was normalized to the area that was HNK-1 positive, reported in
cells/10,000 µm2 (i.e., 100 x 100 µm). Since the average nucleus is roughly 10 µm wide, this
measure is approximately equivalent to the number of apoptotic cells per 100 cells. The same
process was used to evaluate apoptosis within each NCC streak for both cardiac and trunk NCCs.
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The three regions examined for NCC death and migration were the neural tube (NT),
circumpharyngeal ridge (CP), and parapharyngeal arches I-III (PA). The pharyngeal arches are
only included in the cardiac NCC migratory pathway.
The NCC streak area was measured in mm2, and NCC streak intensity was presented as
normalized unitless values. The individual intensities of each migratory streak in each NCC
region (NT, CP, PA) were divided by the average intensity for each region in the NS-treated
embryos for the same batch of embryos. Because fluorescence intensity may vary among batches
of immunohistochemistry, this approach accounted for any batch-specific variation. The EtOHtreated embryo NCC streak intensities were thus compared to NS-treated embryos, whose
fluorescence was arbitrarily normalized to 1.000.
In hearts (HH 31- HH 35), apoptotic cells were counted at the base of the great arteries, where
the neuron branching measurements, such as average branch length (mm) and total branch length
(mm), were taken using NeuronJ.
E. Statistical analysis

Averages and standard deviation (n<9 for all groups) or standard error (n>10 for all groups) were
collected for each measure. A two-tailed t-test was run in Excel to compare neuron branching
data and cardiac apoptosis data. ANOVA followed by a Tukey post hoc analysis was used to
determine significance between groups of three or more. Fisher’s exact test was used to evaluate
categorical data. For all tests, P<0.05 indicated a significant difference.
F. Ethical considerations

Chick embryo usage was confined to the embryonic period (<11 days of incubation), which
Public Health Services Policy has determined does not require IACUC oversight.
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VI. Results
A. Treatment at 24 h reduces embryo viability at day 8

Survival was impacted when early-stage embryos were exposed to EtOH (Figure 1). Embryos
were exposed to EtOH (EtOH) or NS (NS) at 24 h incubation to target the cardiac NC. Embryo
survival initially decreased at a similar rate for NS- and EtOH-treated embryos when dosed at 24
h (Figure 1). At the early days of harvest, a slight but non-significant increase in survival rate
was observed for NS-treated embryos compared with the EtOH-treated embryos. By day 8, the
survival rate stabilized in NS-treated embryos, whereas EtOH-treated embryos showed a
significantly decreased survival rate (p<0.001; NS=47.69%, n=27 versus EtOH=14.35%, n=43).

70%
60%
50%

Percent 40%
Survival 30%

EtOH

***

20%

NS

10%
0%

3

5

8

Harvest Date
Figure 6. Reduced survival in day 8 embryos after treatment with NS (NS) or EtOH (EtOH) at 24 h of incubation. Survival was
assessed at the day of harvest. *** p<0.001 vs NS.

B. Treatment at 48 h has no effect on embryo viability

When embryos were treated with NS or EtOH at 48 h (Figure 2), no significant differences were
found in the survival rates of the two groups. Embryonic survival rates varied more for embryos
dosed at 48 h compared with embryos dosed at 24 h.
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Figure 7. Survival after treatment with NS (NS) or EtOH (EtOH) at 48 h of incubation. Survival was assessed at the day of
harvest.

One final batch of embryos was dosed at 72 h, after cardiac and trunk NCC have been specified
and delaminated. No difference in survival was observed between embryos treated with NS and
those treated with EtOH. However, the sample size was small for this group (NS, n=4; EtOH,
n=4), and 72-hour dosing would need to be repeated to confirm this finding.
a) Treatment at 24 h leads to altered cardiac NCC streak area at day 3
Embryos were treated with NS or EtOH at 24 h and incubated until day 3. At this stage, NCCsare
actively migrating through the circumpharyngeal ridge. Migration was assessed using the
migratory NCC marker Hnk-1, and apoptotic cells were labeled with LysoTracker Red (Figure
3). In this figure it appears that EtOH treatment at 24 h decreases apoptosis in the cardiac NCC
region of the neural tube, increases apoptosis in the cardiac circumpharyngeal ridge, and
decreases NCC streak intensity in the cardiac circumpharyngeal ridge (Figure 3B). Apoptosis
appears to increase in pharyngeal arch I and NCC streak intensity appears to increase in
pharyngeal arch II as NCC migrate towards the heart (Figure 3B). EtOH treatment also appears
to decrease apoptosis in the trunk region of the neural tube and increase apoptosis in the in the
trunk region of the circumpharyngeal ridge (Figure 3D). To better assess the migratory and
apoptotic trends, the extent of migration and the proportion of cells undergoing apoptosis were
measured (Figures 4 and 5).
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Figure 8. EtOH treatment at 24 h increases apoptosis (red) along the migratory pathway towards the OFT and decreases NCC
streak intensity (green) in the cardiac circumpharyngeal ridge.
After 24 hr treatment, NS-treated embryos show apoptosis in the neural tube and low apoptosis along the migratory pathway
from the circumpharyngeal ridge to the pharyngeal arches (III), and toward the OFT (A). EtOH-treated embryos show increased
apoptosis in the cardiac and trunk circumpharyngeal ridge and pharyngeal arches (B and D). There is more apoptosis in the
trunk neural tube of the NS-treated embryo (C) compared to the EtOH treated-embryo (D). Roman numerals = pharyngeal arch
#, o = otic placode, OFT = outflow tract, IFT = inflow tract, FL = forelimb, H = heart.

Apoptosis was quantified throughout the NCC migratory pathway at day 3, starting from the NT
through the PA. When comparing the number of apoptotic cells within this pathway, apoptosis
occurred more frequently in the circumpharyngeal ridge than in the pharyngeal arches, when
focusing on cardiac NCC streaks of embryos dosed at 24 h (p<0.0001, Figure 4). In the
circumpharyngeal ridge, embryos had an average of 7.6 apoptotic cells per 10,000 µm2 (n=10)
after treatment with NS and 7.7 apoptotic cells per 10,000 µm2 (n=15) after treatment with EtOH
(p=n.s. versus NS). In contrast, in the pharyngeal arches, embryos had an average of 3.6
apoptotic cells per 10,000 µm2 (n=29) after treatment with NS and 2.5 apoptotic cells per 10,000
µm2 (n=38) in EtOH-treated embryos. Thus, regardless of treatment, these two regions show
significant differences in the level of apoptosis.
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Figure 9. Average number of apoptotic cells (±SE) per 10,000 µm2 within cardiac and trunk NCC regions of day 3 embryos
dosed with EtOH and NS at 24 h.
Bars with the same letter show no significant differences, whereas bars with different letters are significantly different
(p<0.0001).

To determine whether these differences in apoptosis were related to the migratory regions, HNK1 area and intensity were measured to evaluate NCC migration (Figure 5). The difference
between NCC streak area in the cardiac NCC region of the neural tube (NS .058 mm2 n=10,
EtOH .0531 mm2 n=2), cardiac circumpharyngeal ridge (NS.1101 mm2 n=10 , EtOH .0806 mm2
n=16) and pharyngeal arches (NS .0311 n=28, EtOH .0357 mm2 n=34) reflects the anatomy of
these regions. The area of the circumpharyngeal ridge is greater than the area of the neural tube
and the area of the neural tube is greater than the area of the pharyngeal arches.
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Figure 10. NCC area (mm2) in day 3 embryos dosed with EtOH and NS at 24 h. Average (+/-SE) NCC streak area in mm2 are
reported for groups treated at 24 h and measured at day 3.
There is a significant difference in the average cardiac NCC streak area in the neural tube, circumpharyngeal ridge, and
pharyngeal arches (p<.01 for all pair-wise comparisons, Tukey post hoc). Bars with the same letter show no significant
differences, whereas bars with different letters are significantly different (p<0.05)

Though not significant, the trunk NCC streak areas are low relative to the cardiac NCCs streaks.
This may reflect the developmental stage of day three embryos compared to day five embryos
when trunk NCCs are migrating in more abundance.
In addition to the differences in anatomical cardiac NCC regions there are also differences
between EtOH treated-embryos NCC regions and NS-treated embryo NCC regions. The
migratory streak area decreases in the circumpharyngeal ridge as well as in the neural tube and
increases in the pharyngeal arches.
While there were significant differences in NCC streak area between NS-and EtOH-treated
embryos, there was no significant difference in cardiac or trunk NCC streak intensity in day 3
embryos after treatment at 24 h (data not shown).
C. EtOH exposure at 24 h increases apoptosis in cardiac NCC and intensity in both
cardiac and trunk in day 5 embryos

Embryos were treated with NS or EtOH at 24 h and incubated until day 5. At this stage, NCCs
have migrated into the pharyngeal arches and are approaching the heart. Migration was assessed
using the migratory NCC marker Hnk-1, and apoptotic cells were labeled with LysoTracker Red
(Figure 6). Apoptosis and NCC streak intensity appears to increase in pharyngeal arches III and
24

IV of 24 h treated embryos (Figure 6 B). EtOH treatment at 24 h also seems to increase NCC
streak intensity in the trunk circumpharyngeal ridge (Figure 6 D). To better assess the migratory
and apoptotic trends, the extent of migration and the proportion of cells undergoing apoptosis
were measured (Figures 7 and 8).

Figure 11. Migratory streak intensity increases in both cardiac and trunk NCC migratory streaks, and apoptosis in cardiac NCC
increases in day 5 embryos treated with EtOH at 24 h. NS cardiac NCC (A), EtOH cardiac NCC (B), NS trunk NCC (C), and
EtOH trunk NCC (D). Roman numerals = pharyngeal arch #, o = otic placode, H = heart.

Apoptosis was quantified throughout the NCC migratory pathway at day 5, starting from the NT
through the PA. EtOH had a significant impact on apoptosis within all regions of the NCC
migratory pathway in embryos treated at 24 h (Figure 7). EtOH appears to decrease apoptosis in
the neural tube, from 3.922 (n=1) to 0.000 (n=2) cells, but the small sample sizes limit any
analysis in this region. EtOH treatment significantly increases apoptosis from 0.000 cells (n=4)
in the circumpharyngeal ridge of NS-treated embryos to 16.858 apoptotic cells in the EtOH
treated embryo (n=15). Apoptosis in pharyngeal arches increase from 0.000 in NS-treated
embryos (n=3) to 18.511 cells in EtOH-treated embryos (n=6). EtOH does not affect one region
more than other regions in the cardiac NCC of day 5 embryos. The effect of EtOH treatment at
24 hr of incubation on trunk NCCs in day 5 embryos cannot be determined since data is lacking
for trunk NCC apoptosis in NS-treated embryos.
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Figure 12. Average (±SE) apoptotic cells per 10,000 µm2 within cardiac and trunk NCC regions of day 5 embryos dosed with
EtOH and NS at 24 h.
EtOH treatment at 24 h of incubation decreases apoptosis in the neural tube (NT) and increases apoptosis in the CP and PA.
Bars with the same letter show no significant differences, whereas bars with different letters are significantly different (p<0.05,
two-wav ANOVA followed by Tukey post hoc analysis).

As in the day 3 analysis, apoptosis was compared with migratory NCC streak size and intensity.
After EtOH treatment at 24 h of incubation, the NCC streak intensity in the circumpharyngeal
ridge of the cardiac NCC increases two-fold relative to the NS controls (NS, 1.000, n= 6 versus
EtOH, 2.016, n=16). The intensity of the NCC streak in the circumpharyngeal ridge of the trunk
NCC increased four-fold, from 1.000 (n=21) in NS-treated embryos to 4.338 (n=32) in EtOHtreated embryos. The intensity of the migratory streaks within the pharyngeal arches remained
the same after treatment.
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Figure 13. NCC streak intensity increases in day 5 embryos dosed at 24 h. Average (+/-SE) streak intensity are reported for
groups treated at 24 h and measured at day 5.
EtOH treatment (b) at 24 h significantly increases streak intensity in the trunk and cardiac regions of the circumpharyngeal
ridge as measured by a two-way ANOVA and followed by Tukey post hoc analysis. Bars with the same letter show no significant
differences, whereas bars with different letters are significantly different (p<.01, vs NS).

Although the migratory streak area was affected in day three embryos treated at 24 h (Figure 5),
EtOH exposure at 24 h had no significant impact on migratory streak area in day five embryos.
D. NCC streak area in day 3 embryos shows differences between anatomical regions but
is not affected by EtOH treatment at 48 hour

Day 3 embryos treated with EtOH and NS at 48 h showed similarities in NCC streak with day 3
embryos treated at 24 h (Figure 5). Average pharyngeal arch streak area was measured to be
significantly smaller than neural tube area (p<.01). Average neural tube area in NS embryos was
0.0227 mm2 (n=1) and 0.0243 mm2 (n=1) in EtOH. Average pharyngeal arch area in NS
embryos was 0.0041 mm2 (n=3) and 0.0069 mm2 (n=10) in EtOH-treated embryos, showing an
estimated four-times difference between the two regions, though the limited sample size restricts
conclusions of biological significance. EtOH treatment at 48 h does not significantly affect the
NCC streak area in these regions, nor does it affect the amount of apoptosis occurring in these
NCC streaks.
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Figure 14. Number of Average (±SE) apoptotic cells per 10,000 µm2 within cardiac and trunk NCC regions of day 3 embryos
dosed with EtOH and NS at 48 h.
Apoptosis seems to increase substantially in the neural tube, circumpharyngeal ridge, and pharyngeal arches from day 3 to day
5. However, these data are not statistically significant.

E. EtOH exposure at 48 h affects NCC apoptosis and Hnk-1 intensity in embryos
harvested at day 5

Embryos were treated with NS or EtOH at 48 h and incubated until day 5. At this stage, trunk
NCCs are actively migrating through the circumpharyngeal ridge. Migration was assessed using
the migratory NCC marker Hnk-1, and apoptotic cells were labeled with LysoTracker Red
(Figure 10). In this figure it appears that compared to an NS-treated embryo (Figure 10A) the
EtOH-treated embryo shows increased apoptosis in all parts of the migratory pathways, and
especially in the three pharyngeal arches (Figure 10B). EtOH treatment at 48 h seems to reduce
intensity of trunk NCC streaks migrating through the circumpharyngeal ridge. To better assess
the migratory and apoptotic trends, the intensity of migration and the proportion of cells
undergoing apoptosis were measured (Figures 11 and 12).
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Figure 15. In embryos treated at 48 h and harvested at day 5, more apoptosis is observed in the cardiac CP than in the trunk CP,
while NCC streak intensity increases for both regions. NS cardiac NCC (A), EtOH cardiac NCC (B), NS trunk NCC (C), EtOH
trunk NCC (D). Roman numerals = pharyngeal arch #, o = otic placode, OFT = outflow tract, FL = front limb, V = ventricle,
and At = atrium

Apoptosis was quantified throughout the NCC migratory pathway at day 5, starting from the NT
through the PA (Figure 11). In the cardiac region of the neural tube, apoptosis significantly
decreased from 6.9 cells (n=3) after NS treatment to 1.0 cells after EtOH treatment (n=3). Trunk
NCC apoptosis increased significantly in the neural tube from 0.0 cells (n=3) after NS treatment
to 1.1 cells (n=3) after EtOH treatment. In the cardiac circumpharyngeal ridge, apoptosis
significantly increased after EtOH treatment, from 6.5 cells (n=21) after NS treatment to 7.3 cells
(n=20) after EtOH treatment. Apoptosis in the trunk circumpharyngeal ridge significantly
decreased from 3.2 cells (n=18) in NS-treated embryos to 3.1 in EtOH-treated embryos (n=38).
EtOH treatment at 48 h significantly increased apoptosis in the pharyngeal arches from 2.3 cells
(n=7) in control embryos to 7.8 (n=13) in EtOH-treated embryos.

29

14
12

b,c
10

a

b,c
a

# Apoptotic 8
Cells/100 cells 6

EtOH-C

a,d

4
2

NS-C

b,c

b

NS-T

a

EtOH-T

b
a,d

0
NT

CP

PA

NCC Region
Figure 16. 48 hour treatment effects apoptosis in NCC regions of day 5 embryos.
Average (+/-SE) # apoptotic cells/10,000 µm2 are reported for groups treated at 48 h and measured at day 5. Bars with the same
letter show no significant differences, whereas bars with different letters are significantly different. There is a significant
difference between NS-treated NCC apoptosis and EtOH -treated apoptosis as measured by a two-way ANOVA followed by
Tukey post hoc analysis (p<.01). There is also a significant difference between cardiac NCC apoptosis in EtOH-treated embryos
and trunk NCC apoptosis in NS-treated embryos (p<.05).

NS-treated embryos showed decreasing levels of apoptosis as the NCCstravel the migratory
pathway from the neural tube to the pharyngeal arches, while the embryos treated at 48 h of
incubation with EtOH appear to show the opposite trend of apoptosis increasing along the
migratory pathway.
While there was no significant difference in NCC streak intensity among the NCC migratory
pathway in day 3 embryos treated at 48 h, EtOH treatment at 48 h increased trunk migratory
streak intensity in the circumpharyngeal ridge in day 5 embryos. Intensity in the cardiac
circumpharyngeal ridge significantly decreased from one 1.0 (n=20) to 0.9 (n=37) while
intensity in the trunk circumpharyngeal ridge increased from 1.0 (n=39) to 3.5 (19) representing
a much higher magnitude of change after EtOH treatment.
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Figure 17. NCC streak intensity in day 5 embryos dosed with EtOH and NS at 48 h.
Average (+/-SD) streak intensity is reported for groups treated at 48 h and measured at day 5. Bars with the same letter show no
significant differences, whereas bars with different letters are significantly different. EtOH treatment at 48 h significantly impacts
NCC streak intensity compared to NS treatment (P<.05). EtOH treatment at 48 h significantly impacts trunk NCC in the CP
ridge more than cardiac NCC in the circumpharyngeal ridge as measured by an ANOVA and followed by Tukey post hoc
analysis (p<.0001).

EtOH treatment at 48 h seems to properly target the trunk NCC migrating in the CP and
increases NCC populations in this region.
F. Treatment at 24 h does not disrupt cardiac innervation

Because increased apoptosis was observed within the migrating NCC after EtOH treatment at 24
h (Figure 4), innervation was examined at day 8. Although cardiac NCC streaks in the
circumpharyngeal ridge increases in intensity and decreases in area, cardiac innervation is
unaffected after 24 hr treatment.
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Figure 18. Day 8 hearts dosed at 24 h show no significant difference between EtOH-treated embryo (B) compared to a NStreated embryo (A). NS heart (A), EtOH-treated heart representative of data (B), deviant EtOH-treated heart (C). RA = right
atrium; LA = left atrium; Ao = aorta.

Targeting cardiac NCC by treating embryos at 24 h with EtOH appeared to decrease the average
number of branches from 62.2 in NS-treated controls to 37.9 in the EtOH-treated embryos and
the total neuron length from 17.22 mm in NS-treated controls to 9.48 mm in the EtOH-treated
embryos. However, there were no significant difference in the number of neuronal branches,
length per branch, and total neuron length between the EtOH- and NS-treated groups.
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Figure 19. Neuron branching patterns in day 8 hearts are unaffected after treatment with EtOH at 24 h.
Number of branches (A), branch length (mm) (B), and total branch length (mm) (C) all appear to decrease after treatment at 24
h. NS, n=10. EtOH, n=10. These data, however, are not significant (p>0.05, two-tailed t-test).

G. EtOH treatment at 24 h has no effect on cardiac apoptosis

Apoptosis was examined at the base of the heart, counting the number of apoptotic cells within
the neural plexus (Figure 15). Embryos were examined at day 8, after parasympathetic
innervation has begun. While cardiac apoptosis appears to decrease after EtOH treatment at 24 h,
this difference is not significant (p=n.s.).
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Figure 20. Apoptosis at the base of the OFT in day 8 hearts is unaffected by EtOH treatment at 24 h.
Average (± SD) number of apoptotic cells/10,000 μm2 between heart samples from NS- and EtOH-treated embryos shows no
significant difference (p>0.05, two-sided t-test).

H. Late EtOH treatment decreases neuronal branching

To determine the effects of altered early migration and apoptosis, cardiac innervation was
examined after EtOH exposure at 48 h (Figure 16). The day 8 heart of an embryo treated with
EtOH at 48 h seems to exhibit persistent truncus arteriosus and reduced overall size with not
much change to neuron morphology (Figure 16B) compared to the NS-treated heart (Figure
16A). The day 8 heart of an embryo treated with EtOH at 48 h shows reduced neuronal
branching (Figure 16D) compared to the NS-treated heart (Figure 16C).
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Figure 21. Day 7 heart dosed at 48 h (B) shows possible persistent truncus arteriosus and an increase in apoptosis at the
anterior base of the OFT while day 8 heart shows reduced branching and neuron length (D) compared to a NS-treated embryo
(A, C). RA = right atrium; LA = left atrium; ?PTA = speculated persistent truncus arteriosus.

The neuronal branching patterns were then quantified (Figure 17), focusing on the number of
neuronal branches, the length of each branch, and the total length of the neurons of the anterior
plexus.
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Figure 22. Neuron branching is altered by EtOH at exposure at 48 h during initial branching.
Number of branches (A), branch length (mm) (B), and total branch length (mm) (C) vary in day 7 and day 8 hearts after
treatment at 48 h. *p<0.05 versus NS..
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Branching significantly decreases in day 7 hearts from 52 branches (n=3) to 47.5 branches (n=3)
after EtOH treatment at 48 h of incubation (Figure 17A). Average branch length and total branch
length also appear to decrease from day 7 to day 8 (Figure 17B and C), though these differences
are not statistically significant.
I. EtOH treatment at 48 h does not affect apoptosis in cardiac neurons
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Figure 23. EtOH treatment at 48 h does not affect apoptosis in day 7 or day 8 hearts. Although EtOH treatment at 48 h appears
to increase cardiac apoptosis in day eight hearts, this result is not significant (p=n.s., two-tailed t-test).

VII.

Discussion

A. Early ethanol exposure reduces embryo viability at day 8

When embryos were treated with ethanol at 24 h, survival decreased with increasing time, and
embryos harvested at day 5 appeared particularly vulnerable to mortality (Figure 7). Survival
decreased for both normal saline- and ethanol-treated embryos from day 3 to day 5, and increases
at day 8. Although the data comparing day 3 and day 5 are not significantly different, there are
genetic variabilities that alter embryonic viability when exposed to ethanol (Debelak and Smith
2000).
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Because there was some variability in chicken breeds used, this variability may lead to any of the
variabilities in survival data of embryos when harvested at day 3, 5, or 8.

While the viability of embryos treated at 24 hours of incubation was significantly impacted, tthe
viability of embryos treated at 48 hours of incubation was not significantly altered by ethanol
(Figure 8). This finding suggests that targeting the trunk NCC at 48 hours of incubation is less
detrimental to vital NCC -dependent development than targeting the cardiac NCC at 24 hours of
incubation, and that later-stage ethanol exposure may result in less severe symptoms of FASD.
The variation in viability in different chicken breeds may also account for the lack of
significance e in data for embryos harvested treated at 48 hours of incubation.
B. Early ethanol exposure induces neural crest cell apoptosis in migratory streaks of the
cardiac circumpharyngeal ridge within day 3 embryos

In day 3 embryos, more apoptosis was observed within the cardiac circumpharyngeal ridge than
in the pharyngeal arches, regardless of whether the embryos were treated at 24 hours with
ethanol or normal saline (Figure 10). At day 3, the NCCspause within the circumpharyngeal
arch, and cell death may be more prominent within the CP than in the pharyngeal arches due to
this pause (Kuratani & Kirby, 1992).

Although ethanol treatment at 48 hours was used to target trunk NCC , this treatment did not
affect apoptosis within migratory NCC in day 3 embryos. Day 3 embryos may not be
representative of normal trunk cell migration and therefore may not be representative of the
effects of ethanol on trunk NCC migration and apoptosis. While trunk NCC begins migrating at
HH 11-15, migration, it is not complete until HH 19, which is roughly day 3.5 of incubation
(Giovannone, et al. 2016). Accurate harvest timing after 3.5 days of incubation may assure
proper targeting.

C. Ethanol treatment alters apoptosis in the neural tube and migratory neural crest cell
in day 5 embryos
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After ethanol treatment at 24 hours of incubation, apoptosis in the neural tube decreases whereas
apoptosis in the cardiac CP and PA increases (Figure 13). The decrease in apoptosis in the neural
tube suggests that NCC type specification is occurring at a higher rate after ethanol treatment
than after normal saline treatment. Apoptosis increased further along the migratory pathway, in
the circumpharyngeal ridge and pharyngeal arches, suggesting that fewer of the NCCsthat have
delaminated from the neural tube are reaching the heart. This finding could be explained by an
increase in calcium transients in the NCC after ethanol exposure (Karunamuni et al., 2014).
Ethanol impairs calcium regulation: high calcium in NCCsleads to apoptosis, whereas calcium
levels are downregulated in the developing heart, leading to decreased contractility. Correcting
these calcium levels, in which high calcium is required in the developing heart and is detrimental
in the NCC s, could restore the NCC survival and migration through the circumpharyngeal ridge
and outflow tract. Furthermore, contractility in the developing heart can be restored if the
calcium transient is increased. Further research can investigate this directionality of calcium
transients in cardiac development. Dosing at 24 hours seems to have properly targeted NCC
migration and induced apoptosis.
While ethanol treatment at 24 hours significantly decreased apoptosis in the neural tube of the
cardiac region, ethanol treatment at 48 hours significantly increased apoptosis in the neural tube
of the trunk region (Figure 17). Similar to embryos treated at 24 hours, ethanol treatment at 48
hours increases apoptosis in the cardiac CP; however, this increase is smaller than is observed
after the early exposure. The 48-hour treatment seems to specifically target trunk region of the
neural tube, and apoptosis in trunk CP changes to a lesser degree. Apoptosis in the PA
significantly increased after ethanol treatment at 48 hours. Cardiac NCC may still be affected
during later stages of development due to this increased apoptosis, although the NCC have
exited the PA and entered the OFT by this stage of development.

(Giovannone et al. 2015). Thus, ethanol exposure can have multiple detrimental effects on
cardiac development, depending on the exposure timing. NCCsin the trunk region of the neural
tube may be more vulnerable to ethanol-related cell death than other regions of the trunk NCC
migratory pathway.

39

D. Early ethanol treatment alters cardiac neural crest cell migration throughout the
migratory pathway

After the 24-hour ethanol treatment, the migratory NCC streaks in the neural tube and the
circumpharyngeal ridge decreased in size whereas the migratory streaks increased in the
pharyngeal arches of day 3 embryos (Figure 11). Since apoptosis increased in the
circumpharyngeal ridge, the migratory streak area may decrease due to the decreased number of
NCCspresent in the streaks examined. However, this shift does not account for the decrease in
migratory streak area in the cardiac NT and the increased size in PA, where the apoptosis trends
do not explain the changes in migratory streak size.

The increase in NCC streak intensity for both ethanol treatment groups suggests that there is an
increase in non-specific cell migration along the migratory pathway (Figure 14). Early exposure
to ethanol may affect not only the cardiac NCC but also trunk NCC migration. An increase in
intensity after ethanol treatment may signify more cells migrating or more densely packed cells
migrating as a counter-response to the increased apoptosis in the circumpharyngeal ridge of the
cardiac NCC migratory pathway. Data for trunk apoptosis in normal saline-treated embryos are
insufficient to draw conclusions, but we hypothesize that apoptosis would be increased
significantly in the circumpharyngeal ridge after ethanol treatment at 24 hours ssincee intensity
increases in this region.

Intensity in the trunk NCC circumpharyngeal ridge is also increased after 48 hour treatment
since apoptosis decreased slightly (Figure 18).
E. Later ethanol treatment may alter neural crest cell migration in the
circumpharyngeal ridge

Ethanol treatment at 48 hours does not significantly affect the trunk CP migratory streak area;
however, the migratory streaks appears less specific in direction (Figure 16).
F. Later ethanol treatment decreases neuron branching at the anterior base of the
outflow tract in day 7 hearts
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A decrease in day 7 cardiac neuron branching could be due to 48 hour ethanol exposure targeting
the trunk neural crest and delaying onset of sympathetic innervation (Figure 23). Lateral
inhibition may occur as trunk neural crest cell intensity increases and activates the branching
inhibition. This may also lead to a change in heart rate. Other studies have found an
overexpression in adrenergic receptors on the heart, suggesting compensation for this delayed
onset of sympathetic innervation (Bond 1988, Zimmerberg et al., 1996).
G. Ethanol treatment does not alter apoptosis at the anterior base of the outflow tract in
day 7 or 8 hearts

Though no significant change occurred in apoptosis after 24 or 48 hour treatment in day 7 and
day 8 hearts, this could possibly be due to the reduced role of apoptosis during these stages
(Figure 21 and 24). Apoptosis likely plays a more important role during the morphological
changes to the outflow tract. The role of cardiac neural crest cell apoptosis in cardiac neuron
development in later stages remains understudied. However, with a larger sample size, the results
may show that apoptosis does indeed decrease with ethanol exposure leading to decreased
calcium transients and decreased apoptosis in the heart (Karunamuni et al., 2014).
VIII.

Conclusion

In conclusion, variable timing of ethanol exposure targets the trunk neural crest and the cardiac
neural crest differently. Intriguingly, the later stage ethanol exposure affects apoptosis and neural
crest migration in both regions.

Early ethanol exposure decreases apoptosis in the neural tube and increases apoptosis in the
cardiac region of the circumpharyngeal ridge at a higher magnitude than it is increased in the
pharyngeal arches of day 3 and day 5 embryos. Apoptosis decreased in the neural tube for
embryos exposed to ethanol at an early stage. Early ethanol exposure reduced survival in chick
(Gallus gallus) at day 8 of incubation. This increase in apoptosis in the pharyngeal arches at day
5 is also reflected in embryos exposed to ethanol at a later stage, but to a lesser degree. For those
embryos exposed to ethanol at a later stage, the trunk region of the neural tube is the most
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vulnerable to increased apoptosis, though apoptosis increases in the circumpharyngeal ridge of
trunk region, as well. Decreased neuronal branching was found at the anterior base of the
outflow tract after later ethanol exposure, suggesting that the increased neural crest cell death
could negatively impair sympathetic neuron branch morphology in day 7 hearts. Although late
stage ethanol exposure was hypothesized to target trunk neural crest cells, it also increased
apoptosis in the cardiac neural crest cells. Increased apoptosis began at the start of the migratory
pathway and increased toward the outflow tract of the developing heart.

Cardiac neural crest streak area is decreased in the circumpharyngeal ridge and is increased in
the pharyngeal arches of day 3 embryos after early exposure. Intensity of trunk neural crest cell
streak increases in the circumpharyngeal ridge more than cardiac neural crest cell streak intensity
increases after later stage ethanol treatment in day 5 embryos, though both are affected.

The variation in the data prompted the researchers to question the relationship between neural
crest cell streak area, intensity, apoptosis and how these reflect the migratory pathway of the
neural crest to their target organ systems. Further studies can analyze the cell signaling
molecules that affect the direction, potency, and limitations of the migratory neural crest streak.
These signaling molecules may be differentially affected by ethanol and have widespread effects
beyond the neural crest. Repeated studies can be conducted with larger sample sizes and more
specific immunofluorescent antibodies to understand how the changes in neural crest cell
migration and apoptosis affect parasympathetic and sympathetic cardiac innervation throughout
development.
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